FLT3-IN-12
FLT3-IN-12 is a potent, selective and orally active FLT3 kinase inhibitor with IC50s of 1.48 nM and 2.87 nM for FLT3-WT and FLT3-D835Y, respectively. FLT3-IN-12 possesses high selectivity over c-KIT (>1000-fold). FLT3-IN-12 has an excellent anti-AML (acute myeloid leukemia) activity (MV4-11, IC50 of 0.75 nM).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2499966-67-3
- Formule: C21H23F3N6O
- Masse moléculaire:432.44
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
IC50: 1.48 nM (FLT3-WT) and 2.87 nM (FLT3-D835Y)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BaF3 | IC50 |
0.16 nM
Compound: 36
|
Antiproliferative activity against mouse BaF3 cells expressing FLT3-D835F mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against mouse BaF3 cells expressing FLT3-D835F mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| BaF3 | IC50 |
0.84 nM
Compound: 36
|
Antiproliferative activity against mouse BaF3 cells expressing FLT3-ITD mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against mouse BaF3 cells expressing FLT3-ITD mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| BaF3 | IC50 |
1.17 nM
Compound: 36
|
Antiproliferative activity against mouse BaF3 cells expressing FLT3-ITD-D835Y double mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against mouse BaF3 cells expressing FLT3-ITD-D835Y double mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| BaF3 | IC50 |
1.29 nM
Compound: 36
|
Antiproliferative activity against mouse BaF3 cells expressing FLT3-D835V mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against mouse BaF3 cells expressing FLT3-D835V mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| BaF3 | IC50 |
1398 nM
Compound: 36
|
Antiproliferative activity against mouse BaF3 cells expressing wild type FLT3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against mouse BaF3 cells expressing wild type FLT3 assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| BaF3 | IC50 |
14.5 nM
Compound: 36
|
Antiproliferative activity against mouse BaF3 cells expressing FLT3-ITD-F691L double mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against mouse BaF3 cells expressing FLT3-ITD-F691L double mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| BaF3 | IC50 |
3.56 nM
Compound: 36
|
Antiproliferative activity against mouse BaF3 cells expressing FLT3-F691L mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against mouse BaF3 cells expressing FLT3-F691L mutant assessed as inhibition of cell proliferation measured after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| HeLa | IC50 |
2067.33 nM
Compound: 36
|
Antiproliferative activity against human Hela cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against human Hela cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| Kasumi 1 | IC50 |
131.1 nM
Compound: 36
|
Antiproliferative activity against human Kasumi-1 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against human Kasumi-1 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| MCF7 | IC50 |
271.3 nM
Compound: 36
|
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against human MCF-7 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| MM1.S | IC50 |
1208.5 nM
Compound: 36
|
Antiproliferative activity against human MM.1S cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay
Antiproliferative activity against human MM.1S cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay
|
[PMID: 35138851] |
| MV4-11 | IC50 |
0.75 nM
Compound: 36
|
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability after 72 hrs by CellTiter-Glo assay
|
[PMID: 35138851] |
| MV4-11 | IC50 |
0.75 nM
Compound: A1
|
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability incubated for 72 hrs by CellTiter 96 Aqueous One Solution Cell Proliferation Assay
|
[PMID: 37584545] |
| PBMC | IC50 |
1735.67 nM
Compound: 36
|
Antiproliferative activity against human PBMC cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against human PBMC cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| WI-38 | IC50 |
1618.67 nM
Compound: 36
|
Antiproliferative activity against human WI-38 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against human WI-38 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
| Z-138 | IC50 |
>200 nM
Compound: 36
|
Antiproliferative activity against human Z138 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
Antiproliferative activity against human Z138 cells assessed as reduction in cell viability after 72 hrs by celltiter-glo luminescent cell viability assay
|
[PMID: 35138851] |
In Vitro
FLT3-IN-12 (compound 36) efficiently inhibits the growth of multiple mutant BaF3 cells expressing FLT3-ITD, FLT3-D835V/F, FLT3-F691L, FLT3-ITD-F691L, and FLT3-ITD-D835Y with the IC50 range is 0.16-14.5 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
FLT3-IN-12 (compound 36; 20 mg/kg; oral administration) exhibits excellent plasma exposure (area under the curve (AUC)0–∞ of 5278 ng·h/mL), T1/2 of 3.7 hours, and high maximum plasma concentrations (Cmax of 775 ng/mL)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2499966-67-3
-
Masse moléculaire 432.44
-
Formule C21H23F3N6O
-
SMILES
O=C1C2=CC=C(NC3=NC=C(C(F)(F)F)C(N[C@@H]4CC[C@@H](CC4)N)=N3)C=C2C=CN1C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)